EPO Patent Publication: Anti-CD30 Monoclonal Antibodies and Chimeric Antigen Receptors

ChangeBridge: EPO Bulletin - Peptides (C07K)

Published March 11th, 2026

Detected March 26th, 2026

Summary

The European Patent Office has published patent application EP4301783A1 concerning anti-CD30 monoclonal antibodies and chimeric antigen receptors. The publication lists NantBio, Inc. as the applicant and details several inventors. This patent publication is part of the EPO Bulletin.

View original document View source feed page

What changed

The European Patent Office (EPO) has published patent application EP4301783A1, titled 'Anti-CD30 Monoclonal Antibodies and Chimeric Antigen Receptors'. The application was filed by NantBio, Inc. and lists multiple inventors. The publication date is March 11, 2026, and it falls under the C07K classification for peptides.

This is a patent publication, not a regulatory rule or enforcement action. It does not impose new compliance obligations or deadlines on regulated entities. Companies in the pharmaceutical and biotechnology sectors may wish to review the patent details for competitive intelligence or potential licensing opportunities.

Source document (simplified)

← EPO Patent Bulletin

ANTI-CD30 MONOCLONAL ANTIBODIES AND CHIMERIC ANTIGEN RECEPTORS

Publication EP4301783A1 Kind: A1 Mar 11, 2026

Applicants

NantBio, Inc.

Inventors

OLSON, Clifford Anders, NIAZI, Kayvan, ADISETIYO, Helty, GARBAN, Hermes J., GUIDO, Mark, MCFARLANE, Heather, TRINH, Tan, TANAKA, Shiho

IPC Classifications

C07K 16/28 20060101AFI20250318BHEP C07K 14/725 20060101ALI20250318BHEP C07K 14/705 20060101ALI20250318BHEP A61P 35/00 20060101ALI20250318BHEP A61K 39/00 20060101ALI20250318BHEP A61K 40/15 20250101ALI20250318BHEP A61K 40/31 20250101ALI20250318BHEP A61K 40/42 20250101ALI20250318BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →